MRI Interventions Announces Participation in Upcoming Investor Conferences

IRVINE, Calif., June 11, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, today announced the Company will be presenting at two investment conferences in the month of June.

MRI Interventions' Chief Financial Officer David Carlson will present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference on Friday, June 13, 2014 in New York City. The presentation is scheduled to begin at 1:00 p.m. EDT.

Chief Executive Officer Kimble Jenkins will present at the JMP Securities Healthcare Conference on Tuesday, June 24, 2014 in New York City. The presentation is scheduled to begin at 3:30 p.m. EDT. A live webcast of this presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.

About MRI Interventions

Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint® system is designed to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. For more information, please visit www.mriinterventions.com.

CONTACT: MRI Interventions, Inc.
         David Carlson
         (901) 522-9300

Released June 11, 2014